KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E Adjustments
Ratios

TherapeuticsMD (TXMD) Depreciation Expense: 2011-2023

Historic Depreciation Expense for TherapeuticsMD (TXMD) over the last 3 years, with Dec 2023 value amounting to -$185,000.

  • TherapeuticsMD's Depreciation Expense rose 34.86% to -$185,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $100,000, marking a year-over-year decrease of 83.33%. This contributed to the annual value of $100,000 for FY2023, which is 83.33% down from last year.
  • Per TherapeuticsMD's latest filing, its Depreciation Expense stood at -$185,000 for Q4 2023, which was down 242.31% from $130,000 recorded in Q3 2023.
  • TherapeuticsMD's 5-year Depreciation Expense high stood at $329,000 for Q1 2022, and its period low was -$284,000 during Q4 2022.
  • In the last 2 years, TherapeuticsMD's Depreciation Expense had a median value of $129,000 in 2023 and averaged $87,500.
  • As far as peak fluctuations go, TherapeuticsMD's Depreciation Expense soared by 73.05% in 2019, and later plummeted by 91.79% in 2023.
  • Quarterly analysis of 3 years shows TherapeuticsMD's Depreciation Expense stood at $66,493 in 2019, then reached -$284,000 in 2022, then skyrocketed by 34.86% to -$185,000 in 2023.
  • Its Depreciation Expense was -$185,000 in Q4 2023, compared to $130,000 in Q3 2023 and $128,000 in Q2 2023.